Abstract
In recent years, immobilized peptides synthesized on activated cellulose membranes (SPOT synthesis, Frank 1992) have become an important tool in the study of protein-protein interactions and numerous other aspects of molecular recognition (reviewed in Reineke et al. 2001). A broad range of applications has already been described and the rising interest in proteomics is bound to rely on the enormous potential of the (automated) method. When adapted to high-throughput screening, SPOTs, i.e. peptide arrays, will become an invaluable tool in pharmacogenomics and drug discovery.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Blüthner M, Mahler M, Müller DB, Dünzl H, Bautz FA (2000) Identification of an alpha-helical epitope region on the PM/Scl-100 autoantigen with structural homology to a region on the heterochromatin p25beta auto antigen using immobilized overlapping synthetic peptides. J Mol Med 78: 47–54
Fack F, Hügle-Dörr B, Song D, Queitsch I, Petersen G, Bautz EKF (1997) Epitope mapping by phage display: random versus gene-fragment libraries. J Immunol Methods 206: 43–52
Frank R (1992) SPOT synthesis: an easy technique for the positionally addressable, parallel chemical synthesis on a membrane support. Tetrahedron 48: 9217–9232
Hoffmann WL, Jump AA (1986) Tween-20 removes antibodies and other proteins from nitrocellulose. J Immunol Methods 94: 191–196
Kenna JG, Major GN, Williams RS (1985) Methods for reducing non-specific antibody binding in enzyme-linked immunosorbent assays. J Immunol Methods 85: 409–419
Kramer A, Keitel T, Winkler K, Stöcklein W, Höhne W, Schneider-Mergener J (1997) Molecular basis for the binding promiscuity of an anti-p24 (HIV-1) monoclonal antibody. Cell 91: 799–809
Mahler M, Mierau R, Blüthner M (2000) Fine-specificity of the anti CENP-A B-cell autoimmune response. J Mol Med 78: 460–467
Mohammad K, Esen A (1989) A blocking agent and a blocking step are not needed in ELISA, immunostaining dot-blots and western blots. J Immunol Methods 117: 141–145
Peterfi Z, Kocsis B (2000) Comparison of blocking-agents for an ELISA for LPS. J Immunoassays 21: 341–354
Pruslin FH (1991) Caveats and suggestions for the ELISA. J Immunol Methods 137: 27–35
Reineke U, Volkmer-Engert R, Schneider-Mergener J (2001) Applications of peptide arrays prepared by the SPOT-technology. Curr Opin Biotechnol 12: 59–64
Thean ET, Toh BH (1989) Western immunoblotting: temperature-dependent reduction in background staining. Anal Biochem 177: 256–258
Vogt RF Jr, Phillips DL, Henderson LO, Whitfield W, Spierto FW (1987) Quantitative differences among various proteins as blocking agents for ELISA microtiter plates. J Immunol Methods 101: 43–50
Wobus C, Hügle-Dörr B, Girod A, Petersen G, Hallek M, Kleinschmidt JA (2000) Monoclonal antibodies against the adeno-associated virus type 2 (AAV-2) capsid: epitope mapping and identification of capsid domains involved in AAV-2-cell interaction and neutralization of AAV-2 infection. J Virol 74: 9281–9293
Zampieri S, Ghirardello A, Doria A, Tonello M, Bendo R, Rossini K, Gambari PF (2000) The use of Tween-20 in immunoblotting assays for the detection of autoantibodies in connective tissue diseases. J Immunol Methods 239: 1–11
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2002 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Bräuning, R., Mahler, M., Hügle-Dörr, B., Blüthner, M., Koch, J., Petersen, G. (2002). Immobilized Peptides to Study Protein-Protein Interactions — Potential and Pitfalls. In: Koch, J., Mahler, M. (eds) Peptide Arrays on Membrane Supports. Springer Lab Manuals. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-09229-3_11
Download citation
DOI: https://doi.org/10.1007/978-3-662-09229-3_11
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-07639-8
Online ISBN: 978-3-662-09229-3
eBook Packages: Springer Book Archive